Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders

This publication has 14 references indexed in Scilit:

• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
  Published by Elsevier ,1998
• The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
  Journal of General Virology, 1998
• Outcome of orthotopic liver transplantation in patients with haemophilia
  Gut, 1998
• Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
  The Lancet, 1997
• Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers
  Journal of Hepatology, 1997
• Case Report: Granulomatous Hepatitis in a Patient with Chronic Hepatitis C Treated with Interferon-α
  Digestive Diseases and Sciences, 1997
• A combined management protocol for patients with coagulation disorders infected with hepatitis C virus
  British Journal of Haematology, 1996
• The natural history of chronic hepatitis C in haemophiliacs
  British Journal of Haematology, 1996
• Ribavirin as Therapy for Chronic Hepatitis C
  Annals of Internal Medicine, 1995